Narsico, Rosemarie .

HRN: 11-32-58  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2022
AMPICILLIN 1GM (VIAL)
07/15/2022
07/21/2022
IV
2g
Q6
PROM
Waiting Final Action 
07/18/2022
CEFUROXIME 500MG (TAB)
07/18/2022
07/25/2022
ORAL
500mg/tab
BID
S/P NSVD; PROM
Waiting Final Action 
07/18/2022
METRONIDAZOLE 500MG (TAB)
07/18/2022
07/18/2022
ORAL
500mg Tab
TID
Thinly Meconium Stained Amniotic Fluid
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: